Company intelligence / Profile preview

C.S. Wallace Investments & Strategy

Ownership: Private
Development stage: Other

Overview

C.S. Wallace Investments & Strategy is an investment and advisory firm specializing in animal health, human healthcare, and agribusiness. It invests in, advises, and provides strategic support to early- and mid-stage companies in these sectors. The firm does not conduct its own drug development or clinical trials but supports the growth of portfolio companies through capital, expertise, and industry connections.

Industry: Investors

Partnerships

1C (via board membership of Craig S. Wallace)KeraVet Bio (via board membership of Craig S. Wallace)CATalyst Council (via Craig S. Wallace as Secretary)

Beyond the preview

Go deeper on C.S. Wallace Investments & Strategy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on C.S. Wallace Investments & Strategy.

Explore the full profile